Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,936,438
  • Shares Outstanding, K 103,483
  • Annual Sales, $ 4,416 M
  • Annual Income, $ 192,790 K
  • 60-Month Beta 1.80
  • Price/Sales 2.23
  • Price/Cash Flow 18.92
  • Price/Book 3.07
Trade SYNH with:

Options Overview Details

View History
  • Implied Volatility 28.74%
  • Historical Volatility 13.48%
  • IV Percentile 8%
  • IV Rank 15.41%
  • IV High 58.86% on 01/27/21
  • IV Low 23.26% on 09/13/21
  • Put/Call Vol Ratio 0.25
  • Today's Volume 5
  • Volume Avg (30-Day) 61
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 128
  • Open Int (30-Day) 213

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 1.04
  • Number of Estimates 3
  • High Estimate 1.05
  • Low Estimate 1.03
  • Prior Year 0.93
  • Growth Rate Est. (year over year) +11.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
89.09 +8.10%
on 09/17/21
97.47 -1.20%
on 09/14/21
+6.49 (+7.23%)
since 08/24/21
3-Month
83.00 +16.04%
on 08/09/21
97.47 -1.20%
on 09/14/21
+10.00 (+11.59%)
since 06/24/21
52-Week
50.58 +90.39%
on 09/25/20
97.47 -1.20%
on 09/14/21
+45.02 (+87.78%)
since 09/24/20

Most Recent Stories

More News
Syneos Health's (SYNH) New Buyout Boosts Clinical Solutions Arm

Syneos Health (SYNH) acquisition of StudyKIK strengthens the former's ability to provide technology and insight-driven solutions.

OMCL : 154.25 (-1.31%)
HSIC : 78.10 (+0.64%)
SYNH : 96.31 (+0.30%)
BRBR : 31.81 (-0.28%)
Syneos Health (SYNH) Enhances Clinical Trials With New Pact

Syneos Health (SYNH) recent partnership develops a more patient-centric travel experience, advances diversity and inclusion in clinical research.

HSIC : 78.10 (+0.64%)
SYNH : 96.31 (+0.30%)
NVST : 43.28 (+1.45%)
BRBR : 31.81 (-0.28%)
Novan Announces Strategic Priorities and Outlines Key Milestones

- Company planning for three potential New Drug Application (NDA) filings in three years with the first submission expected in Q3 2022 for lead program SB206 in molluscum contagiosum -

NOVN : 8.14 (-3.78%)
SYNH : 96.31 (+0.30%)
Syneos Health (SYNH) Up 11.8% Since Last Earnings Report: Can It Continue?

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SYNH : 96.31 (+0.30%)
Novan Engages Syneos Health as Commercial Solutions Provider for SB206

- Company targeting New Drug Application (NDA) for SB206 in Q3 2022, following recent clinically and statistically significant topline efficacy results from a pivotal Phase 3 B-SIMPLE4 trial in patients...

NOVN : 8.14 (-3.78%)
SYNH : 96.31 (+0.30%)
Syneos Health (SYNH) Hits a 52-Week High: What's Driving It?

Strong performance by the Clinical Solutions and Commercial Solutions segments drove Syneos Health's (SYNH) top line.

LH : 296.37 (-0.12%)
OMCL : 154.25 (-1.31%)
CPSI : 35.51 (-1.06%)
SYNH : 96.31 (+0.30%)
Syneos Health to Present at the 2021 Baird Global Healthcare Conference

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs...

SYNH : 96.31 (+0.30%)
Syneos Health (SYNH) Q2 Earnings Top Estimates, 2021 View Up

Syneos Health (SYNH) reported better-than-expected revenues for the second quarter of 2021 on strong segmental performance.

WST : 457.11 (+0.42%)
BRKR : 84.58 (-0.34%)
SYNH : 96.31 (+0.30%)
EHC : 77.01 (+0.86%)
Syneos Health (SYNH) Surpasses Q2 Earnings and Revenue Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 3.19% and 0.71%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 96.31 (+0.30%)
Syneos Health Reports Second Quarter 2021 Results

Highlights

SYNH : 96.31 (+0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Syneos Health Inc. is an integrated biopharmaceutical solutions organization. It includes a Contract Research Organization and Contract Commercial Organization to accelerate customer performance to address modern market realities. Syneos Health Inc., formerly known as INC Research Holdings Inc., is based...

See More

Key Turning Points

3rd Resistance Point 100.54
2nd Resistance Point 98.90
1st Resistance Point 97.61
Last Price 96.31
1st Support Level 94.68
2nd Support Level 93.04
3rd Support Level 91.75

See More

52-Week High 97.47
Last Price 96.31
Fibonacci 61.8% 79.56
Fibonacci 50% 74.03
Fibonacci 38.2% 68.50
52-Week Low 50.58

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar